Company
BelgiumGlaxoSmithKline Biologicals SA, Wavre, Belgium – FDA Inspections
Inspection records and compliance data for GlaxoSmithKline Biologicals SA in Wavre. 3 FDA inspections on record, 2 Form 483s, last inspected February 27, 2026.
Company Profile
This profile covers GlaxoSmithKline Biologicals SA based in Wavre, Belgium.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 3
- Form 483s
- 2
- Warning letters
- 0
First inspected June 24, 2019. Last inspected February 27, 2026.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Environmental Monitoring System1 inspection
- input/output verification1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 27, 2026 | Not classified | Biologics · Vaccine, Allergenic, and Live Biotherapeutic Products | 1305486 |
| June 23, 2023 | Not classified | Biologics | 1214970 |
| June 24, 2019 | Not classified | Biologics | 1099401 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
GlaxoSmithKline Biologicals SA
FEI Number
3003973577
Address
Avenue Fleming 20, Parc De La Noire Epine, Wavre, Belgium
Country
Belgium
ID: 9a234513-4162-49b8-b149-5c1be5aa9090